Dr. Andreas Krause to Present on Statistical Considerations for Model Selection and Bias; Dr. Klaas Prins to Present on Modeling and Simulation
MOUNTAIN VIEW, Calif., Sept. 4 /PRNewswire-FirstCall/ -- Pharsight Corporation (OTC Bulletin Board: PHST), a leading provider of software and strategic services for optimizing clinical drug development, today announced that Pharsight senior scientists will deliver two presentations to biopharmaceutical industry statisticians attending the annual ROeS Seminar (Austrian-Swiss Region of the International Biometric Society), to be held in Bern, Switzerland on September 9-13, 2007. Andreas Krause, Ph.D., senior biostat-istician, Strategic Consulting Services, will present a model-based approach to assess clinical study data for potentially confounding effects; Klaas Prins, Ph.D., senior scientist, Strategic Consulting Services, will present methods for extracting and integrating public-source scientific literature in modeling and simulation analyses.
Drs. Krause and Prins will present applied case studies at two ROeS seminar sessions, each of which will provide a forum for pharmaceutical scientists from industry and academia to have a collaborative exchange on model-based approaches. Pharsight's two presentations are:
-- September 10: Modeling and simulation to adjust p-values in presence
of a regression to the mean effect.
Dr. Krause will present this case study as part of a dedicated
conference session on selection procedures and bias. The session will
include applied examples of statistical methods to enable model-based
drug development, and will describe research on how modeling and
simulation has been used to analyze and monitor clinical information.
-- September 11: Modeling and simulation using metadata: away from
inventing the wheel again.
Dr. Prins will present
|SOURCE Pharsight Corporation|
Copyright©2007 PR Newswire.
All rights reserved